Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening

November 12, 2020 Leave a comment 1,610 Views

Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced today the launch of a pioneering ultra-high-throughput SARS-CoV-2 test that will allow for the first time a true mass screening of the whole population. This test allows ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: public health

Lexogen has developed the first commercial Covid-19 ultra-high-throughput test for true public health mass screening

Do you wonder what 10X data looks like on the newest Illumina sequencer?

Single-cell RNA sequencing finds senescent immune cells promote lung tumor growth

Establishment of a hybridoma sequencing pipeline for sequencing of antibody variable regions

RNA-seq identifies stochastic RNA editing of synaptic genes in single neurons

NVIGEN pioneers breakthrough in high-resolution tissue RNA sequencing with magnetic nanoparticle capture

RNA folding studies by tRNA structure-seq inside peptide-rich droplets reveal roles of modified nucleosides at the origin of life

GiRAFR – gRNA detection and annotation in single-cell CRISPR screens